Osong Public Health and Research Perspectives,
Год журнала:
2022,
Номер
13(2), С. 84 - 100
Опубликована: Апрель 27, 2022
The
coronavirus
disease
2019
(COVID-19)
pandemic
rapidly
spread
globally.
Severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
which
causes
COVID-19,
is
a
positive-sense
single-stranded
RNA
virus
with
reported
fatality
rate
ranging
from
1%
to
7%,
and
people
immune-compromised
conditions,
children,
older
adults
are
particularly
vulnerable.
Respiratory
failure
cytokine
storm-induced
multiple
organ
the
major
of
death.
This
article
highlights
innate
adaptive
immune
mechanisms
host
cells
activated
in
response
SARS-CoV-2
infection
possible
therapeutic
approaches
against
COVID-19.
Some
potential
drugs
proven
be
effective
for
other
viral
diseases
under
clinical
trials
now
use
Examples
include
inhibitors
RNA-dependent
polymerase
(remdesivir,
favipiravir,
ribavirin),
protein
synthesis
(ivermectin,
lopinavir/ritonavir),
fusion
membrane
(chloroquine,
hydroxychloroquine,
nitazoxanide,
umifenovir).
also
presents
intellectual
groundwork
ongoing
development
vaccines
preclinical
trials,
explaining
candidates
(live
attenuated-whole
vaccines,
inactivated
subunit
DNA-based
protein-based
nanoparticle-based
virus-like
particles
mRNA-based
vaccines).
Designing
developing
an
vaccine
(both
prophylactic
therapeutic)
would
long-term
solution
most
way
eliminate
COVID-19
pandemic.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(5), С. 641 - 641
Опубликована: Апрель 23, 2023
Licorice,
a
natural
medicine
derived
from
the
roots
and
rhizomes
of
Glycyrrhiza
species,
possesses
wide
range
therapeutic
applications,
including
antiviral
properties.
Glycyrrhizic
acid
(GL)
glycyrrhetinic
(GA)
are
most
important
active
ingredients
in
licorice.
Glycyrrhetinic
3-O-mono-β-d-glucuronide
(GAMG)
is
metabolite
GL.
GL
its
metabolites
have
activities
against
viruses,
such
as,
hepatitis
virus,
herpes
virus
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
so
on.
Although
their
activity
has
been
widely
reported,
specific
mechanism
action
involving
multiple
links
as
itself,
cells,
immunity
not
clearly
established.
In
this
review,
we
will
give
an
update
on
role
agents,
detail
relevant
evidence
potential
use
mechanisms
actions.
Analyzing
antivirals,
signaling,
impacts
tissue
autoimmune
protection
may
provide
promising
new
strategies.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(8), С. 4543 - 4543
Опубликована: Апрель 21, 2024
Type
II
pneumocytes
are
the
target
of
SARS-CoV-2
virus,
which
alters
their
redox
homeostasis
to
increase
reactive
oxygen
species
(ROS).
Melatonin
(MT)
has
antioxidant
proprieties
and
protects
mitochondrial
function.
In
this
study,
we
evaluated
whether
treatment
with
MT
compensated
for
alteration
in
serum
from
COVID-19
patients.
We
determined
oxidative
stress
(OS)
markers
such
as
carbonyls,
glutathione
(GSH),
total
capacity
(TAC),
thiols,
nitrites
(NO2-),
lipid
peroxidation
(LPO),
thiol
groups
serum.
also
studied
enzymatic
activities
peroxidase
(GPx),
glutathione-S-transferase
(GST),
reductase
(GR),
thioredoxin
(TrxR),
extracellular
superoxide
dismutase
(ecSOD)
peroxidases.
There
were
significant
increases
LPO
carbonyl
quantities
(p
≤
0.03)
decreases
TAC
NO2-,
GSH
<
0.001)
The
enzymes
ecSOD,
TrxR,
GPx,
GST,
GR,
peroxidases
decreased
0.04)
after
treatment.
favored
activity
that
contributed
an
restored
lost
homeostasis.
modulated
glucose
homeostasis,
functioning
a
glycolytic
agent,
inhibited
Warburg
effect.
Thus,
restores
is
altered
patients
can
be
used
adjuvant
therapy
infection.
Microorganisms,
Год журнала:
2023,
Номер
11(4), С. 1000 - 1000
Опубликована: Апрель 12, 2023
Coronavirus
disease
(COVID-19)
has
killed
millions
of
people
since
first
reported
in
Wuhan,
China,
December
2019.
Intriguingly,
Withania
somnifera
(WS)
shown
promising
antiviral
effects
against
numerous
viral
infections,
including
SARS-CoV
and
SARS-CoV-2,
which
are
contributed
by
its
phytochemicals.
This
review
focused
on
the
updated
testing
therapeutic
efficacy
associated
molecular
mechanisms
WS
extracts
their
phytochemicals
SARS-CoV-2
infection
preclinical
clinical
studies
with
aim
to
develop
a
long-term
solution
COVID-19.
It
also
deciphered
current
use
silico
docking
approach
developing
potential
inhibitors
from
targeting
host
cell
receptors
that
may
aid
development
targeted
therapy
ranging
prior
entry
until
acute
respiratory
distress
syndrome
(ARDS).
discussed
nanoformulations
or
nanocarriers
achieving
effective
delivery
enhance
bioavailability
efficacy,
consequently
preventing
emergence
drug
resistance,
eventually
failure.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(4), С. 591 - 591
Опубликована: Апрель 14, 2023
SARS-CoV-2
infects
type
II
pneumocytes
and
disrupts
redox
homeostasis
by
overproducing
reactive
oxygen
species
(ROS).
N-acetyl
cysteine
(NAC)
is
a
precursor
of
the
synthesis
glutathione
(GSH)
it
restores
loss
associated
to
viral
infections.
The
aim
study
evaluate
effect
treatment
with
NAC
on
enzymatic
antioxidant
system
in
serum
from
patients
infected
SARS-CoV-2.
We
evaluated
activities
thioredoxin
reductase
(TrxR),
peroxidase
(GPx),
-S-transferase
(GST),
(GR)
spectrophotometry
concentrations
(GSH),
total
capacity
(TAC),
thiols,
nitrites
(NO2-),
lipid
peroxidation
(LPO)
serum.
activity
extracellular
super
oxide
dismutase
(ecSOD)
was
determined
native
polyacrylamide
gels,
3-nitrotyrosine
(3-NT)
measured
ELISA.
A
decrease
ecSOD,
TrxR,
GPx,
GST
GR,
(p
=
0
≤
0.1),
GSH,
TAC,
NO2-
0.001)
an
increase
LPO
3-NT
were
found
COVID-19
vs.
healthy
subjects.
as
adjuvant
therapy
may
contribute
reduction
OS
infection
through
generation
GSH.
GSH
promotes
metabolic
pathways
that
depend
it,
thus
contributing
TAC
restore
homeostasis.
Type
II
pneumocytes
are
the
target
of
SARS-CoV-2
which
alters
their
redox
homeostasis
to
increase
reactive
oxygen
species
(ROS).
Melatonin
(MT)
has
antioxidant
proprieties
and
protects
mitochondrial
function.
Here
we
evaluated
whether
treatment
with
MT
compensated
for
alteration
in
serum
from
COVID-19
patients.
We
determined
oxidative
stress
(OS)
markers
such
as
carbonyls,
glutathione
(GSH),
total
capacity
(TAC),
thiols,
nitrites
(NO2–),
lipid
peroxidation
(LPO),
thiols
groups
serum.
also
studied
enzymatic
activities
peroxidase
(GPx),
-S-transferase
(GST),
reductase
(GR),
thioredoxin
(TrxR),
extracellular
superoxide
dismutase
(ecSOD)
peroxidases.
There
was
a
significant
LPO
carbonyls
(p≤0.03)
decrease
TAC,
NO2–,
GSH,
(p&lt;0.001)
The
ecSOD,
TrxR,
GPx,
GST,
GR
peroxidases
were
decreased
(p≤
0.04).
favored
activity
enzymes
contributed
TAC
restored
lost
homeostasis.
modulated
glucose
functioning
glycolytic
agent
inhibited
Warburg
effect.
Thus,
restores
is
altered
patients
can
be
used
adjuvant
therapy
infection.
ACS Catalysis,
Год журнала:
2024,
Номер
14(5), С. 3687 - 3699
Опубликована: Фев. 21, 2024
The
development
of
technologies
for
the
efficient
synthesis
innovative
antiviral
compounds
remains
an
important
challenge
modern
biotechnology,
especially
in
context
recent
COVID-19
pandemic.
One
drugs
that
is
currently
research
spotlight
potential
anti-SARS-CoV-2
activity
purine
mimetic
prodrug
compound
T-705,
also
known
as
favipiravir.
Along
with
a
similar
compound,
T-1105,
activation
T-705
limited
by
low
rate
phosphoribosylation,
mediated
enzyme
named
hypoxanthine-guanine
phosphoribosyltransferase
(HGPRT).
Therefore,
phosphoribosylated/ribosylated
derivatives
these
prodrugs
viable
direction
discovery
and
pharmaceuticals.
However,
chemical
such
complex
laborious
process,
whereas
enzymatic
cascades
are
not
feasible
because
narrow
HGPRT
substrate
specificity.
Here,
we
report
successful
rational
design
biocatalyst
T-705/T-1105
phosphoribosylation.
With
two
rounds
Thermus
thermophilus
HB27
active
site
optimization,
have
achieved
325-fold
increase
kcat
toward
125-fold
T-1105
accompanied
multifold
decrease
KM.
practical
applicability
designed
mutant
was
illustrated
through
preparative
nucleotide
derivatives.
Our
engineered
can
become
basis
chemoenzymatic
various
proven
activity.
Moreover,
our
results
provide
insight
into
molecular
mechanism
including
experimental
evidence
explaining
reasons
behind
compounds.
Journal of Advanced Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 1, 2025
Alpha-herpesvirus
poses
significant
health
risks
to
humans
and
challenges
animal
husbandry.
Currently,
the
clinically
approved
antiviral
drug
Acyclovir
exhibits
limitations,
including
resistance
adverse
effects.
The
development
of
broad-spectrum
agents
against
alpha-herpesvirus
is
urgently
needed.
This
study
aimed
discover
a
novel
with
capacity
broadly
inhibit
various
alpha-herpesviruses.
In
this
study,
we
conducted
high-content
screening
1,500
chemical
compounds
identify
potential
candidates.
mechanisms
were
explored
using
phenotypic
experiments,
untargeted
metabolomics,
molecular
docking.
We
discovered
that
Antimycin
A
effectively
inhibits
replication
alpha-herpesviruses,
herpes
simplex
virus
1
(HSV-1),
bovine
herpesvirus
(BHV-1),
pseudorabies
(PRV).
Our
revealed
viral
by
disrupting
formation
pyrimidinosomes
are
essential
for
efficient
infection.
Finally,
inhibited
infection,
prevented
tissue
damage,
enhanced
survival
in
PRV-infected
BALB/c
mice,
confirming
its
vivo
efficacy.
emerges
as
promising
lead
candidate
therapies
infections.
Microorganisms,
Год журнала:
2023,
Номер
11(8), С. 2096 - 2096
Опубликована: Авг. 16, 2023
Remdesivir
is
the
first
FDA-approved
drug
for
treating
severe
SARS-CoV-2
infection
and
targets
RNA-dependent
RNA
polymerase
(RdRp)
that
required
viral
replication.
To
monitor
development
of
mutations
may
result
in
remdesivir
resistance
during
prolonged
treatment,
we
sequenced
specimens
collected
at
different
treatment
time
points
two
transplant
patients
with
COVID-19.
In
patient,
an
allogeneic
hematopoietic
stem
cell
recipient,
a
transient
RdRp
catalytic
subunit
mutation
(nsp12:A449V)
was
observed
has
not
previously
been
associated
resistance.
As
no
vitro
study
had
conducted
to
elucidate
phenotypic
effect
nsp12:A449V,
its
clinical
significance
unclear.
second
other
were
detected:
one
(nsp12:V166A)
accessory
important
processivity
(nsp7:D67N).
This
case
report
potential
link
between
nsp12:V166A
vivo,
which
only
described
by
studies.
The
nsp7:D67N
resistance,
whether
it
unknown.
Our
revealed
genetic
dynamics
recipients
involved
complex
(nsp7
nsp12),
be
selective
pressure.
These
results
suggest
close
monitoring
course
highly
vulnerable
patient
populations
beneficial.
Development
utilization
diagnostic
genotyping
tests
future
direction
improving
management
chronic